RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.
How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
RBC Life Sciences, Inc.'s score of 27 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, RBC Life Sciences, Inc. reported total carbon emissions of approximately 22,840,000 kg CO2e from Scope 1 sources and about 65,577,000 kg CO2e from Scope 2 sources. Additionally, the company recorded emissions of around 11,920,000 kg CO2e from Scope 3, specifically related to business travel. Despite these figures, RBC Life Sciences has not established specific reduction targets or initiatives as part of their climate commitments. The company does not inherit emissions data from a parent organisation, indicating that all reported figures are directly from RBC Life Sciences, Inc. As the organisation continues to navigate its environmental impact, it remains crucial for RBC Life Sciences to develop and implement strategies aimed at reducing its carbon footprint in alignment with industry standards and climate action goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 22,840,000 |
| Scope 2 | 64,958,000 |
| Scope 3 | 11,920,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RBC Life Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
